Lenz Therapeutics Stock Market Value
| LENZ Stock | 12.88 0.09 0.69% |
| Symbol | LENZ |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LENZ Therapeutics. Expected growth trajectory for LENZ significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive LENZ Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding LENZ Therapeutics requires distinguishing between market price and book value, where the latter reflects LENZ's accounting equity. The concept of intrinsic value - what LENZ Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push LENZ Therapeutics' price substantially above or below its fundamental value.
Understanding that LENZ Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LENZ Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LENZ Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
LENZ Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LENZ Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LENZ Therapeutics.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in LENZ Therapeutics on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding LENZ Therapeutics or generate 0.0% return on investment in LENZ Therapeutics over 90 days. LENZ Therapeutics is related to or competes with GH Research, ARS Pharmaceuticals, Nanobiotix, Maravai Lifesciences, Rezolute, Geron, and Tyra Biosciences. LENZ Therapeutics is entity of United States More
LENZ Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LENZ Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LENZ Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 40.02 | |||
| Value At Risk | (6.56) | |||
| Potential Upside | 8.05 |
LENZ Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LENZ Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LENZ Therapeutics' standard deviation. In reality, there are many statistical measures that can use LENZ Therapeutics historical prices to predict the future LENZ Therapeutics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (0.80) |
LENZ Therapeutics February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.79) | |||
| Mean Deviation | 3.91 | |||
| Coefficient Of Variation | (790.04) | |||
| Standard Deviation | 5.68 | |||
| Variance | 32.3 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (0.80) | |||
| Maximum Drawdown | 40.02 | |||
| Value At Risk | (6.56) | |||
| Potential Upside | 8.05 | |||
| Skewness | (0.86) | |||
| Kurtosis | 5.5 |
LENZ Therapeutics Backtested Returns
LENZ Therapeutics has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17 % return per unit of volatility over the last 3 months. LENZ Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LENZ Therapeutics' mean deviation of 3.91, and Risk Adjusted Performance of (0.09) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.92, which conveys possible diversification benefits within a given portfolio. LENZ Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, LENZ Therapeutics is expected to follow. At this point, LENZ Therapeutics has a negative expected return of -0.96%. Please make sure to verify LENZ Therapeutics' information ratio, kurtosis, as well as the relationship between the Kurtosis and period momentum indicator , to decide if LENZ Therapeutics performance from the past will be repeated in the future.
Auto-correlation | 0.49 |
Average predictability
LENZ Therapeutics has average predictability. Overlapping area represents the amount of predictability between LENZ Therapeutics time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LENZ Therapeutics price movement. The serial correlation of 0.49 indicates that about 49.0% of current LENZ Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 5.32 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.